Posted on

Victor McKusick, “Mendelian Inheritance in Man”, 1966. Chromosome #19.

Scroll down to see more content

 


Here I present: Victor McKusick, “Mendelian Inheritance in Man”, 1966. Chromosome #19. This print book  consists of twelve (12) editions from 1966 to 1998 (shown ABOVE ).

The following abbreviations may used for Chromosome #19 traits, listed in alphabetical order.

Chromosome 19. 
AMH APOE ARMD1 BCL2
CD97 CD209 CEACAM1 CF CGB
CRLF1 DBA GPI HPS INSR KLK3
KLK4 LIM2 LHB NAPA NPHS1
PCLD PGPEP1 PIN1 PJS PSORS1
RETN RYR1 SCN1 SCN1B SPINT2
TCO TCF3 TGCT TGFB1 TGFR VN1R1.

Coxsackie virus sensitivity.  CXB3S
Ataxia, cerebellar, Cayman type.  ATCAY
Cyclic hematopoiesis.    ELANE
Convulsions, familial febrile.   FEB2
Fucosyltransferase-6 deficiency.   FUT6
Guanidinoacetate methyltransferase deficiency.    GAMT
Hypocalciuric hypercalcemia, type II.  GNA11
Muscular dystrophy.    MDDGC5
Leukemia, myeloid / lymphoid or mixed-lineage.   AML
Hirschsprung disease.   HSCR7
Wegener granulomatosis autoantigen.  PRTN3
Peutz-Jeghers syndrome.   PJS­
Bleeding disorder.   BDPTL11
Leukemia, acute lymphoblastic.  LYL1
Persistent Mullerian duct syndrome, type 1.  PMDS
Atherosclerosis, susceptibility to.  ATHS
Mucolipidosis.   ML4
Malaria, cerebral, susceptibility.   ICAM1
Glutaricaciduria.  GA1
Sicca syndrome.   SLS
Leprechaunism.  INSR
Glioblastoma.   GLTSCR2
Rabson-Mendenhall syndrome.  INSR
Thyroid carcinoma, nonmedullary.  TCO1
Diabetes mellitus, insulin-resistant.  INSR
Low density lipoprotein receptor.  LDLR
Ichthyosis.  ARCI5
Hypercholesterolemia, familial.   FHCL1
Leukemia, T-cell acute lymphoblastoid.   LYL1
Arteriopathy, cerebral.  CADASIL1
Mycobacterial and salmonella infections, susceptibility.  NRAMP1
Pseudoachondroplasia.  COMP
Eye color, green / blue.  EYCL1
Epiphyseal dysplasia, multiple.  EDM1
Hemiplegic migraine, familial.  FHM
Severe combined immunodeficiency disease. SCID
Episodic ataxia, type 2.  EA2
Hair color, brown.  SHEP
Ataxia, spinocerebellar and cerebellar.  SCA6
Leigh syndrome.  LS
Leukemia, acute myeloid.
AML
MHC class II deficiency.  MHC2D2
Mannosidosis, alpha, types I and II. MANSA
Exostoses, multiple, type 3.  EXT3
Alzheimer disease, late onset. AD2
Benign familial infantile convulsions.  BFSI1
Glomerulosclerosis, focal segmental.  FSGS1
Leukemia / lymphoma, B-cell.  BCL3
Deafness, autosomal dominant.  DFNA4A
Spondylocostal dysostisis, autosomal recessive.  SCDO1
Hypercalcemia, familial benign, Oklahoma type, type III.  HHC3
Prostate-specific antigen.
HPCQTL19
Orofacial cleft.  OFC3
Spastic paraplegia antigen.  C19ORF12
Charcot-Leyden crystal protein.  CLC
Cystinuria, types II and III.  CSNU
Hemolytic anemia. GPI
Nephrosis, congenital, Finnish type.  NPHS1
Hydrops fetalis.  CDAN4
Generalized epilepsy with febrile seizures plus.  GEFSP1
Malignant hyperthermia susceptibility.   MHS
Ovarian carcinoma.  CEACAM19
Central core disease.  CCD
Microcephaly, autosomal recessive.  MCPH2
Osteodysplasia, polycystic lipomembranous.  PLOSL
Hyperlipoproteinemia, type Ib and III.  APOE
Maple syrup urine disease, type 1a.  MSUD1A
Myocardial infarction susceptibility.  ATHS
Camurati-Engelmann disease.  CAEND
Cytochrome P450 (coumarin resistance). CYP2A6
Myotonic dystrophy.  DM1
Nicotine addiction, protection from.  CYP2A6
Heart block, progressive familial, type 1.  PFHB1B
X-ray repair.  XRCC1
Optic atrophy.  OPA3
Excision repair.  ERCC1
3-methylglutaconicaciduria, type III.  MGCA3
Xeroderma pigmentosum, group D.  XPD
Cystic fibrosis modifier.  CFM1
Trichothiodystrophy.  TTD1
Meconium ileus in cystic fibrosis, susceptibility to.  CFM1
DNA ligase I deficiency.  LIG1
Osteodysplasia, polycystic lipomembranous.  PLOSL
Polio virus receptor.  PVR
Herpes virus entry mediator.  HVEML
Glutaricaciduria, type IIB.  GA2B
Leber congenital amaurosis.  LCA7
Colorectal cancer.  CRC
Retinitis pigmentosa, late-onset dominant.        RP78
Leukemia, T-cell acute lymphoblastic.  LYL1
Diabetes mellitus, noninsulin-dependent.   INSR
Shaw-related subfamily genes.  KCNC3
Hyperferritinemia-cataract syndrome.  HHCS
Melanoma inhibitory activity.  MIA
Retinitis pigmentosa, autosomal dominant.  RP11
Cardiomyopathy, familial hypertrophic.  CMH7
Ectrodactyly, ectodermal dysplasia, cleft lip / palate.  EEC

Leave a Reply